Suchergebnisse - "Zhang, Li"

PubPharm (361)

1

Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib-refractory ALK-positive NSCLC from a phase II study

enthalten in: Cancer communications (London, England) | 2024

von Zheng, J. | Wang, T. | Yang, Y. | +41

2

Uncommon de novo EGFRT790M-Mutant NSCLC characterized with unique genetic Features : Clinical response and acquired resistance to the third-generation EGFR-TKIs treatment

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Pang, L. | Zhuang, W. | Huang, Y. | +5

3

PDGF-AA guides cell crosstalk between human dental pulp stem cells in vitro via the PDGFR-α/PI3K/Akt axis

enthalten in: International endodontic journal | 2024

von Xu, S. | Wei, J. | Liu, Y. | +9

4

Germline USP36 Mutation Confers Resistance to EGFR-TKIs by Upregulating MLLT3 Expression in Patients with Non-Small Cell Lung Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Guan, S. | Chen, X. | Wei, Y. | +15

5

Brain Radiotherapy With Pyrotinib and Capecitabine in Patients With ERBB2-Positive Advanced Breast Cancer and Brain Metastases : A Nonrandomized Phase 2 Trial

enthalten in: JAMA oncology | 2024

von Yang, Z. | Meng, J. | Mei, X. | +12

6

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK-029A in Treatment-Naive Patients With Advanced NSCLC Harboring EGFR Exon 20 Insertion Mutations : A Phase 1 Trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Duan, J. | Wu, L. | Yang, K. | +32

7

Ningetinib plus gefitinib in EGFR-mutant non-small-cell lung cancer with MET and AXL dysregulations : A phase 1b clinical trial and biomarker analysis

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Zhao, S. | Ma, Y. | Liu, L. | +15

8

QL1706 (anti-PD-1 IgG4/CTLA-4 antibody) plus chemotherapy with or without bevacizumab in advanced non-small cell lung cancer : a multi-cohort, phase II study

enthalten in: Signal transduction and targeted therapy | 2024

von Huang, Y. | Yang, Y. | Zhao, Y. | +12

9

Transformation to small cell lung cancer is irrespective of EGFR and accelerated by SMAD4-mediated ASCL1 transcription independently of RB1 in non-small cell lung cancer

enthalten in: Cell communication and signaling : CCS | 2024

von Ding, X. | Shi, M. | Liu, D. | +7

10

Circulating RNA ZFR promotes hepatocellular carcinoma cell proliferation and epithelial-mesenchymal transition process through miR-624-3p/WEE1 axis

enthalten in: Hepatobiliary & pancreatic diseases international : HBPD INT | 2024

von Zhang, L. | He, S. | Guan, H. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[37]